HUMANES BINDUNGSMOLEKÜL GEGEN CD1A
European patent · EP1706427 · Deleted
Register entry
- Publication number
- EP1706427
- Application number
- EP04804973
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Dec 21, 2004
- Published
- Oct 4, 2006
- Granted
- Dec 7, 2011
- Deleted
- Dec 21, 2024
- Reason
- Maximum term reached
- IPC classes
- C07K 16/28 (2006.01)A61K 39/395 (2006.01)
- Priority
- WO PCT/EP03/51096 23.12.2003WO PCT/EP2004/052110 09.09.2004
- PCT application
- PCT/EP2004/053639 21.12.2004
- PCT publication
- WO2005/063819 14.07.2005
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 21, 2024
Maximum term reached
- Status of protective title
- Active → Cancelled
- Cancellation date
- 21.12.2024
- Cause for cancellation
- Expiry of maximum term of protection
Published in Swissreg on 21.12.2024
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Jan 1, 2023
Change
Published in Swissreg on 01.01.2023
- Jan 14, 2012
Agent entered
- Representative
- BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25
Published in Swissreg on 14.01.2012
- Dec 7, 2011
Granted
Published in Swissreg on 07.12.2011
Parties
Holder
Inventor
THROSBY, Mark
NL-3581 RB Utrecht, NL
VAN MEIJER, Marja
NL-1066 WS Amsterdam, NL
GERMERAAD, Wilfred Thomas Vincent
NL-6247 JA Gronsveld, NL
ARCECI, Robert John
Baltimore, MD 21212, US
KRUISBEEK, Ada Maria
NL-1066 EH Amsterdam, NL
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.